Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pliant Therapeutics (PLRX) Other financing activities (2019 - 2020)

Pliant Therapeutics (PLRX) has disclosed Other financing activities for 2 consecutive years, with -$8000.0 as the latest value for Q4 2020.

  • Quarterly Other financing activities fell 100.31% to -$8000.0 in Q4 2020 from the year-ago period, while the trailing twelve-month figure was -$8000.0 through Sep 2022, down 100.0% year-over-year, with the annual reading at $150000.0 for FY2022, N/A changed from the prior year.
  • Other financing activities for Q4 2020 was -$8000.0 at Pliant Therapeutics, down from $3000.0 in the prior quarter.
  • The five-year high for Other financing activities was $2.6 million in Q4 2019, with the low at -$8000.0 in Q4 2020.